Trials / Completed
CompletedNCT04832087
Pediatric Teduglutide Registry
Pediatric Teduglutide Registry: Clinical Use of Teduglutide in Children With Intestinal Failure, a Multicenter Post-marketing Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 142 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.
Detailed description
This will be a multi-center post-marketing pediatric registry study evaluating the efficacy and safety of teduglutide. This is an observational longitudinal registry of pediatric SBS patients who are using FDA approved teduglutide as per standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teduglutide | Standard of care Teduglutide dosing |
Timeline
- Start date
- 2021-05-18
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2021-04-05
- Last updated
- 2023-12-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04832087. Inclusion in this directory is not an endorsement.